Lambert-Eaton Syndrome Latest Advances

Find the Latest Research About Lambert-Eaton Syndrome

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1101 publications

Early Induction of IVIg Improved the Performance Status and Enabled Chemotherapy Initiation in PCD-LEMS: A Case Report.

Early Induction of IVIg Improved the Performance Status and Enabled Chemotherapy Initiation in PCD-LEMS: A Case Report.

Journal: Internal medicine (Tokyo, Japan)
Published: August 19, 2026

Plasma Exchange-Responsive Bulbar Dysfunction in Thymoma-Associated Myasthenia Gravis with Concomitant Lambert-Eaton Myasthenic Syndrome.

Plasma Exchange-Responsive Bulbar Dysfunction in Thymoma-Associated Myasthenia Gravis with Concomitant Lambert-Eaton Myasthenic Syndrome.

Journal: Internal medicine (Tokyo, Japan)
Published: August 19, 2026

Longitudinal overview of symptomatic and immunosuppressive drugs in LEMS.

Longitudinal overview of symptomatic and immunosuppressive drugs in LEMS.

Journal: Journal of neuromuscular diseases
Published: August 17, 2026

Low-Frequency Repetitive Nerve Stimulation in Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.

Low-Frequency Repetitive Nerve Stimulation in Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.

Journal: Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
Published: June 11, 2026

Neuromuscular Junction Disorders in Children: Approach to Diagnosis and Management.

Neuromuscular Junction Disorders in Children: Approach to Diagnosis and Management.

Journal: Pediatric neurology
Published: May 11, 2026

Lambert-Eaton myasthenic syndrome: Why CMAP and reflexes are not enough.

Lambert-Eaton myasthenic syndrome: Why CMAP and reflexes are not enough.

Journal: Journal of neuroimmunology
Published: May 10, 2026

HSR26-256: Real-World Evidence of Predictors of Time to Amifampridine Discontinuation and Survival in Patients With Cancer-Associated and Non-Cancer-Associated Lambert-Eaton Myasthenic Syndrome in the United States.

HSR26-256: Real-World Evidence of Predictors of Time to Amifampridine Discontinuation and Survival in Patients With Cancer-Associated and Non-Cancer-Associated Lambert-Eaton Myasthenic Syndrome in the United States.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026

Autopsy-Confirmed Non-Paraneoplastic Lambert-Eaton Myasthenic Syndrome with Cerebellar Degeneration: A Case Report.

Autopsy-Confirmed Non-Paraneoplastic Lambert-Eaton Myasthenic Syndrome with Cerebellar Degeneration: A Case Report.

Journal: Diagnostics (Basel, Switzerland)
Published: April 11, 2026

HSR26-256: Real-World Evidence of Predictors of Time to Amifampridine Discontinuation and Survival in Patients With Cancer-Associated and Non-Cancer-Associated Lambert-Eaton Myasthenic Syndrome in the United States.

HSR26-256: Real-World Evidence of Predictors of Time to Amifampridine Discontinuation and Survival in Patients With Cancer-Associated and Non-Cancer-Associated Lambert-Eaton Myasthenic Syndrome in the United States.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026

Fluctuating, but Not Forgotten: Recognizing Neuromuscular Junction Disorders.

Fluctuating, but Not Forgotten: Recognizing Neuromuscular Junction Disorders.

Journal: Emergency medicine clinics of North America
Published: March 27, 2026

Lambert-Eaton myasthenic syndrome in association with Sjögren's syndrome: a case report.

Lambert-Eaton myasthenic syndrome in association with Sjögren's syndrome: a case report.

Journal: Acta neurologica Belgica
Published: March 14, 2026

Clinical approach to neurological paraneoplastic syndromes.

Clinical approach to neurological paraneoplastic syndromes.

Journal: Internal medicine journal
Published: March 11, 2026
Showing 1-12 of 1,101

Last Updated: 09/19/2026